Viewing Study NCT04243434


Ignite Creation Date: 2025-12-25 @ 2:21 AM
Ignite Modification Date: 2026-02-26 @ 4:14 AM
Study NCT ID: NCT04243434
Status: UNKNOWN
Last Update Posted: 2020-04-16
First Post: 2019-10-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients
Sponsor: Acrotech Biopharma Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematologic Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hematology View
None Hematological Malignancy View
None CHOP View
None R-CHOP View